About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Biomarkers in Medicine
›
top-articles
Biomarkers in Medicine
1.8
(top 50%)
impact factor
1.6K
(top 10%)
papers
24.1K
(top 10%)
citations
59
(top 10%)
h
-index
2.0
(top 20%)
impact factor
2.0K
all documents
25.9K
doc citations
92
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies
Biomarkers in Medicine
2010
383
2
Exosomes: the future of biomarkers in medicine
Biomarkers in Medicine
2013
342
3
Current developments in salivary diagnostics
Biomarkers in Medicine
2010
304
4
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
Biomarkers in Medicine
2012
280
5
Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury
Biomarkers in Medicine
2010
275
6
Early diagnosis of pancreatic cancer: challenges and new developments
Biomarkers in Medicine
2012
201
7
Biomarkers of oxidative damage and inflammation in Alzheimer’s disease
Biomarkers in Medicine
2010
191
8
Brain inflammation as a biomarker in epilepsy
Biomarkers in Medicine
2011
182
9
Stability of miRNA in human urine supports its biomarker potential
Biomarkers in Medicine
2013
173
10
CA125 in ovarian cancer
Biomarkers in Medicine
2007
164
11
Blood-based biomarkers of Alzheimer’s disease: challenging but feasible
Biomarkers in Medicine
2010
162
12
Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events
Biomarkers in Medicine
2011
156
13
Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
Biomarkers in Medicine
2010
150
14
Correlating familial Alzheimer’s disease gene mutations with clinical phenotype
Biomarkers in Medicine
2010
145
15
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource
Biomarkers in Medicine
2011
145
16
High-frequency oscillations and other electrophysiological biomarkers of epilepsy: clinical studies
Biomarkers in Medicine
2011
144
17
γ-band abnormalities as markers of autism spectrum disorders
Biomarkers in Medicine
2014
141
18
Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function
Biomarkers in Medicine
2010
137
19
Neuroimaging in amyotrophic lateral sclerosis
Biomarkers in Medicine
2012
133
20
Toward predictive models for drug-induced liver injury in humans: are we there yet?
Biomarkers in Medicine
2014
124
21
hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in Major depressive disorder
Biomarkers in Medicine
2016
119
22
Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosis
Biomarkers in Medicine
2010
117
23
Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies
Biomarkers in Medicine
2010
113
24
Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective
Biomarkers in Medicine
2008
107
25
Molecular biomarkers in stroke diagnosis and prognosis
Biomarkers in Medicine
2009
105
26
The biology of glucagon and the consequences of hyperglucagonemia
Biomarkers in Medicine
2016
102
27
Endothelial function as a functional expression of cardiovascular risk factors
Biomarkers in Medicine
2010
100
28
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease
Biomarkers in Medicine
2012
100
29
Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
Biomarkers in Medicine
2018
95
30
Metabolic pathology of autism in relation to redox metabolism
Biomarkers in Medicine
2014
93
31
Lung cancer epigenetics: emerging biomarkers
Biomarkers in Medicine
2013
89
32
Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice
Biomarkers in Medicine
2010
86
33
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
Biomarkers in Medicine
2016
86
34
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
Biomarkers in Medicine
2014
84
35
Tau as a biomarker of neurodegenerative diseases
Biomarkers in Medicine
2008
83
36
Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology
Biomarkers in Medicine
2011
83
37
Redefining the endophenotype concept to accommodate transdiagnostic vulnerabilities and etiological complexity
Biomarkers in Medicine
2017
83
38
Methods of rapid diagnosis for the etiology of meningitis in adults
Biomarkers in Medicine
2014
81
39
Future of liquid chromatography–mass spectrometry in metabolic profiling and metabolomic studies for biomarker discovery
Biomarkers in Medicine
2007
78
40
Role of hematological parameters in COVID-19 patients in the emergency room
Biomarkers in Medicine
2020
78
41
Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42
Biomarkers in Medicine
2012
76
42
Early detection of ovarian cancer
Biomarkers in Medicine
2008
74
43
Aspects of β-amyloid as a biomarker for Alzheimer’s disease
Biomarkers in Medicine
2007
73
44
Biomarkers in systemic sclerosis
Biomarkers in Medicine
2010
72
45
Circulating microRNAs: potential biomarkers for common malignancies
Biomarkers in Medicine
2015
72
46
Oxidative stress in ischemia and reperfusion: current concepts, novel ideas and future perspectives
Biomarkers in Medicine
2017
71
47
Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic values
Biomarkers in Medicine
2018
71
48
Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis
Biomarkers in Medicine
2020
71
49
Lipidomics applications for disease biomarker discovery in mammal models
Biomarkers in Medicine
2015
70
50
Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Biomarkers in Medicine
2015
70
site/software ©
exaly
; All materials licenced under
CC by-SA
.